Gavi Leap
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn more
Since the middle of 2024, Gavi began a process of re-examining every aspect of the way it works to prepare for its next strategic period. Learn more about this transformation known as the ‘Gavi Leap’.
Learn moreGavi's five-year plan
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Learn more about the five-year strategy setting out the vision and goals that drive our work.
Latest news
View allBoard decisions place country ownership at the heart of a new operating model, reflecting key elements of the Gavi Leap transformation agenda.
Gavi and Global Polio Eradication Initiative Boards convene for second joint session
The Boards of Gavi, the Vaccine Alliance (Gavi) and the Global Polio Eradication Initiative (GPEI) convened to further strengthen collaboration and accelerate progress toward shared goals: reaching zero-dose and under-immunized children with…
Morocco pledges US$ 5 million to Gavi, debuts as a donor to global immunisation efforts
Morocco makes a donation to Gavi, pledging US$ 5 million towards its next strategic period.
What is VaccinesWork?
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn more
VaccinesWork is an award-winning digital platform hosted by Gavi, the Vaccine Alliance covering news, features and explainers from every corner of global health and immunisation.
Learn moreVaccinesWork latest
In a world of finite resources, immunisation advocacy is how Gavi ensures that stakeholders invest in a shared global health security.
Zambia rolls out the malaria vaccine – and not a moment too soon
Health Minister Muchima hails the new childhood jab as “historic and transformative”, even as national data records a spike in infections.
Single-dose dengue vaccine ‘will help Amazon communities’
A world-first single-dose vaccine against dengue virus, manufactured and approved for use in Brazil, will benefit hard-to-reach populations.
